Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04226547 · ClinicalTrials.gov registry record · NA
Amplatzer Amulet LAAO vs. NOAC
A NA study of Stroke and Atrial Fibrillation, sponsored by Abbott Medical Devices.
- Active
- Registry status
- NA
- Development phase
- 2,650
- Enrollment target
- 20
- Study locations
NCT04226547 is a NA study of Stroke and Atrial Fibrillation that is active but no longer recruiting, run by Abbott Medical Devices. The registered enrollment target is 2,650 participants, below the 12,011-participant average among 454 other Stroke trials with a reported enrollment target (78% lower). The trial reports 20 study locations across 7 states.
The verdict
NCT04226547, a NA study of Stroke and Atrial Fibrillation, is active but no longer recruiting, sponsored by Abbott Medical Devices.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 2,650 participants
- Enrollment target
- 20
- Study locations
Study Summary
The objective of this trial is to evaluate the safety and effectiveness of the Amulet LAA occluder compared to NOAC therapy in patients with non-valvular AF at increased risk for ischemic stroke and who are recommended for long-term NOAC therapy. The clinical investigation is a prospective, randomized, multicenter active control worldwide trial. Subjects will be randomized in a 1:1 ratio between the Amulet LAA occlusion device ("Device Group") and a commercially available NOAC medication ("Control Group"). The choice of NOAC in the Control Group will be left to study physician discretion.
Conditions Studied
Interventions
- DEVICE Left Atrial Appendage Occlusion (Amplatzer Amulet LAA Occluder)
- DRUG Non-Vitamin K Oral Antagonists
Study Locations (20)
Florida
- AdventHealth Florida Cardiology - Altamonte Springs - Altamonte Springs
- St. Vincent's Medical Center - Jacksonville
- Baptist Medical Center - Jacksonville
- AdventHealth Florida Cardiology - Lake Mary - Lake Mary
- NCH Healthcare System - Naples
- AdventHealth Orlando - Orlando
- AdventHealth Florida Cardiology - Oviedo - Oviedo
- Sarasota Memorial Hospital - Sarasota
California
- Scripps Health - La Jolla
- Kaiser Permanente Los Angeles Medical Center - Los Angeles
- Huntington Memorial Hospital - Pasadena
- Mercy Medical Group - Cardiology - Sacramento
Alabama
- University Hospital - Univ. of Alabama at Birmingham (UAB) - Birmingham
- Heart Center Research, LLC - Huntsville
Arizona
- Arizona Cardiovascular Research Center - Phoenix
- Tucson Medical Center - Tucson
Arkansas
- Arrhythmia Research Group - Jonesboro
- UAMS Medical Center - Little Rock
Colorado
- South Denver Cardiology Associates PC - Littleton
District of Columbia
- MedStar Washington Hospital Center - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,650 participants |
| Start Date | 2020-07-07 |
| Est. Completion | 2031-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04226547
The ClinicalTrials.gov registry entry for NCT04226547 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 2,650 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,011-participant average among 454 other Stroke trials with a reported enrollment target (78% lower). The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Stroke appearing as the primary indexed condition, and to 2 interventions - of which Left Atrial Appendage Occlusion (Amplatzer Amulet LAA Occluder) is the first listed.
NCT04226547 reports 20 study locations spanning 7 distinct geographic areas - top geographies include Florida, California, Alabama.
Frequently Asked Questions
What is clinical trial NCT04226547 about?
NCT04226547 is a clinical study titled "Amplatzer Amulet LAAO vs. NOAC". The objective of this trial is to evaluate the safety and effectiveness of the Amulet LAA occluder compared to NOAC therapy in patients with non-valvular AF at increased risk for ischemic stroke and who are recommended for long-term NOAC therapy. The clinical investigation is a prospective, randomi...
What is the current status of trial NCT04226547?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 2,650 participants. The study started on 2020-07-07. Estimated completion is 2031-04.
What conditions does trial NCT04226547 study?
This clinical trial studies the following conditions: Stroke, Atrial Fibrillation, Bleeding.
What interventions are being tested in trial NCT04226547?
The interventions under investigation include: Left Atrial Appendage Occlusion (Amplatzer Amulet LAA Occluder) (DEVICE), Non-Vitamin K Oral Antagonists (DRUG).
Who is sponsoring clinical trial NCT04226547?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04226547 being conducted?
This trial has 20 study locations across Alabama, Arizona, Arkansas, California, Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Tracking a Tactile Signal Along the Nervous System
RECRUITING · NA
-
Transcranial Direct Current Stimulation (tDCS) With Verb Network Strengthening Treatment (VNeST) in Chronic Aphasia
RECRUITING · NA
-
Strategy Training for Individuals With Unilateral Neglect
RECRUITING · NA
-
Weight Loss and ExeRcise
RECRUITING · NA
-
Safety and Feasibility of an ExoNET for Supination Assistance for Stroke Survivors
RECRUITING · NA
-
Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.